Jennifer J. Rhodes

Jennifer J. Rhodes

former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate SecretaryatElicio Therapeutics· In proxies 2022–2023

Pay in FY2023+77% from the year before · Elicio Therapeutics stock +2.8% the same year

Jennifer J. Rhodes was paid $1.4M in FY2023 (Dec), up 77%. Elicio Therapeutics stock rose 2.8% that year.

Pay$100 in the stock at the end of FY21 → $29
Pay is from the Summary Compensation Table of each Elicio Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Elicio TherapeuticsPublic company · 4 yr
    • former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary2022 – Present · 4 yrStock in role -93%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?